Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-289
Closed -$28.4K 4914
2025
Q2
$28.4K Buy
289
+176
+156% +$16.7K ﹤0.01% 2291
2025
Q1
$10.7K Buy
113
+42
+59% +$3.87K ﹤0.01% 2403
2024
Q4
$6.54K Sell
71
-24
-25% -$2.2K ﹤0.01% 2632
2024
Q3
$9.17K Sell
95
-13
-12% -$1.27K ﹤0.01% 2300
2024
Q2
$10.5K Buy
108
+65
+151% +$6.03K ﹤0.01% 2200
2024
Q1
$3.96K Sell
43
-2
-4% -$187 ﹤0.01% 2503
2023
Q4
$4.28K Hold
45
﹤0.01% 2335
2023
Q3
$4.2K Buy
45
+10
+29% +$924 ﹤0.01% 2189
2023
Q2
$3.2K Buy
35
+28
+400% +$2.3K ﹤0.01% 2294
2023
Q1
$515 Buy
7
+2
+40% +$173 ﹤0.01% 2834
2022
Q4
$418 Sell
5
-2
-29% -$180 ﹤0.01% 2676
2022
Q3
$1K Buy
7
+4
+133% +$477 ﹤0.01% 2294
2022
Q2
$0 Sell
3
-218
-99% -$27.9K ﹤0.01% 2358
2022
Q1
$38K Buy
+221
New +$33K ﹤0.01% 987
2021
Q4
Sell
-68
Closed -$10K 1913
2021
Q3
$10K Buy
+68
New +$14.1K ﹤0.01% 1330

Other funds holding AMED

Allworth Financial's AMED Position: Q3 2025 in Review

Allworth Financial sold out of Amedisys (AMED) in Q3 2025, closing a stake of 289 shares — an estimated $28.4K sold.

Allworth Financial first reported a position in AMED in Q3 2021 and held it in 15 quarters. The position peaked at $38K in Q1 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Allworth Financial reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Allworth Financial sold 289 Amedisys shares in Q3 2025, an estimated $28.4K.
  • Allworth Financial first reported a position in Amedisys in Q3 2021 and held it in 15 quarters.
  • Allworth Financial's Amedisys position peaked at $38K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Allworth Financial's 13F filing for Q3 2025, filed 2 Dec 2025.